Cargando…
The Anti-Inflammation and Anti-Nociception Effect of Ketoprofen in Rats Could Be Strengthened Through Co-Delivery of a H(2)S Donor, S-Propargyl-Cysteine
PURPOSE: Ketoprofen (KETO) is a traditional non-steroidal anti-inflammatory drug (NSAIDs) with good analgesic and antipyretic effects. However, as NASIDs, the toxicity of KETO towards gastrointestinal (GI) system might limit its clinical use. S-propargyl-cysteine (SPRC) is an excellent endogenous H(...
Autores principales: | Yu, Yue, Yang, Qinyan, Wang, Zhou, Ding, Qian, Li, Meng, Fang, Yudong, He, Qida, Zhu, Yi Zhun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590460/ https://www.ncbi.nlm.nih.gov/pubmed/34785926 http://dx.doi.org/10.2147/JIR.S333326 |
Ejemplares similares
-
S-Propargyl-Cysteine, a Novel Hydrogen Sulfide Donor, Inhibits Inflammatory Hepcidin and Relieves Anemia of Inflammation by Inhibiting IL-6/STAT3 Pathway
por: Wang, Minjun, et al.
Publicado: (2016) -
H(2)S Donor, S-Propargyl-Cysteine, Increases CSE in SGC-7901 and Cancer-Induced Mice: Evidence for a Novel Anti-Cancer Effect of Endogenous H(2)S?
por: MA, Kaium, et al.
Publicado: (2011) -
Effects of S-Propargyl-Cysteine (SPRC) in Caerulein-Induced Acute Pancreatitis in Mice
por: Sidhapuriwala, Jenab N., et al.
Publicado: (2012) -
S-Propargyl-Cysteine Remodels the Gut Microbiota to Alleviate Rheumatoid Arthritis by Regulating Bile Acid Metabolism
por: Wang, Zhou, et al.
Publicado: (2021) -
S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway
por: Wu, Wei-Jun, et al.
Publicado: (2016)